Skip to main content
main-content

01.12.2012 | Review | Ausgabe 1/2012 Open Access

Malaria Journal 1/2012

Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up

Zeitschrift:
Malaria Journal > Ausgabe 1/2012
Autoren:
Rima Shretta, Prashant Yadav
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1475-2875-11-399) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing financial or non-financial interests.

Authors’ contributions

RS and PY drafted the outline and the manuscript and participated in its design. RS coordinated inputs to the draft. All authors have read and approved the final manuscript.

Abstract

The global demand for artemisinin-based combination therapy (ACT) has grown sharply since its recommendation by the World Health Organization in 2002. However, a combination of financing and programmatic uncertainties, limited suppliers of finished products, information opacity across the different tiers in the supply chain, and widespread fluctuations in raw material prices have together contributed to a market fraught with demand and supply uncertainties and price volatility. Various short-term solutions have been deployed to alleviate supply shortages caused by these challenges; however, new mechanisms are required to build resilience into the supply chain. This review concludes that a mix of strategies is required to stabilize the artemisinin and ACT market. First, better and more effective pooling of demand and supply risks and better contracting to allow risk sharing among the stakeholders are needed. Physical and financial buffer stocks will enable better matching of demand and supply in the short and medium term. Secondly, physical buffers will allow stable supplies when there are procurement and supply management challenges while financial buffer funds will address issues around funding disruptions. Finally, in the medium to long term, significant investments in country level system strengthening will be required to minimize national level demand uncertainties. In addition a voluntary standard for extractors to ensure appropriate purchasing and sales practices as well as minimum quality and ethical standards could help stabilize the artemisinin market in the long term.
Zusatzmaterial
Additional file 1: Analysis of approaches for better matching of ACT demand and supply.(DOCX 20 KB)
12936_2012_2625_MOESM1_ESM.docx
Authors’ original file for figure 1
12936_2012_2625_MOESM2_ESM.pdf
Authors’ original file for figure 2
12936_2012_2625_MOESM3_ESM.pdf
Authors’ original file for figure 3
12936_2012_2625_MOESM4_ESM.pptx
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Malaria Journal 1/2012 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise